Kommentar zu „Direkte orale Antikoagulantien verhindern Thrombose-Rezidive bei Tumorpatienten“

• Literatur

• 1 Riess H. et al. Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management. Crit Rev Oncol Hematol 2021; 157: 103125
• 2 Klamroth R. et al. Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study. Oncol Res Treat 2022; 45: 178-185
• 3 Riess H. et al. Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)-German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis. Hamostaseologie 2022; 42: 166-173
• 4 Mulder FI. et al. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis. Blood 2020; 12: 1433-1441
• 5 AWMF-Leitlinie Diagnostik und Therapie der Venenthrombose und Lungenembolie (065–002). 2023 awmf.org